ONFOP — Onfolio Holdings, Inc

Nasdaq · Information Technology · IT Services · CIK 1825452 ·
Last close
Market Cap
52W High
52W Low
ADV30
Next earnings
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. Its lead product is AVERSA Fentanyl, an abuse deterrent fentanyl patch for the treatment of chronic pain. The company also develops AVERSA buprenorphine and AVERSA methylphenidate. It has a commercial development and clinical supply agreement for Aversa Fentanyl with Kindeva Drug Delivery. The company was incorporated in 2016 and is headquartered in Orlando, Florida.
No quarterly fundamentals indexed for this ticker.

Peers — same industry

TickerNameMarket CapLastDaily %
GOOGL Alphabet Inc. $2.04T $348.06
GOOG Alphabet Inc. $1.90T $344.59
META Meta Platforms, Inc. $1.23T $559.02
SPCX SPACE EXPLORATION TECHNOLOGIES CORP $1.02T $135.00
ADP AUTOMATIC DATA PROCESSING INC $112.43B $283.01

Recent Insider Activity

No insider activity indexed for this ticker.